Literature DB >> 17486870

Transfusion and bleeding in coronary artery bypass grafting: an on-pump versus off-pump comparison.

Kieron C Potger1, Darryl McMillan, Joanne Southwell, Terry Connolly, Kate Kingsford Smith, Mark Ambrose.   

Abstract

Blood transfusion rates in coronary artery bypass grafting (CABG) surgery using cardiopulmonary bypass (CPB) are typically higher compared with off-pump CABG (OPCAB). However, few studies have specifically examined intraoperative hemodilution as a contributing factor. The aim of this retrospective review was to compare the effect of using CPB or OPCAB on red blood cell (RBC) transfusion and postoperative bleeding. The lowest intraoperative hematocrit (Hct) was used as marker of intraoperative hemodilution. We reviewed the perioperative data of all isolated CABG patients at a metropolitan hospital from January 2003 to June 2005. Stepwise regression analyses were performed to determine whether CPB was an independent predictor of RBC transfusion, reoperation for bleeding, or postoperative chest drainage. Of a total of 1043 patients, there were 433 CPB and 610 off-pump cases. CPB use was not significantly related to increased RBC transfusions (odds ratio [OR], 0.98; 95% confidence interval [CI], 0.63-1.52; p = .921) and was associated with a lower incidence of reoperations for bleeding (OR, 0.4; 95% CI, 0.2-0.8; p = .009). There was less chest drainage over the first 12 hours in patients undergoing CPB (p < .0001); however, total postoperative chest drainage was not significantly related to operative procedure (p = .122). The lowest documented intraoperative Hct was a significant factor in RBC transfusions (OR, 0.89; p < .0001), an increased reoperation rate for bleeding (OR, 0.9; p = .001) and more postoperative chest drainage (log10-transformed: at 12 hours, b = -0.009, p < .0001; total, b = -0.006, p < .0001). CPB is not an independent risk factor in the incidence of RBC transfusions and is not associated with increased postoperative bleeding for isolated CABG. However, intraoperative hemodilution is an independent risk factor, with a lower intraoperative Hct associated with more RBC transfusions, increased reoperations for bleeding, and increased postoperative chest drainage. Addressing intraoperative hemodilution is important in minimizing CPB-associated morbidities.

Entities:  

Mesh:

Year:  2007        PMID: 17486870      PMCID: PMC4680678     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  28 in total

1.  Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery.

Authors:  Subramaniam Balachandran; Michael H Cross; Sivagnanam Karthikeyan; Anilkumar Mulpur; Stephen D Hansbro; Peter Hobson
Journal:  Ann Thorac Surg       Date:  2002-06       Impact factor: 4.330

2.  Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.

Authors:  Sandra Dial; Eugene Delabays; Martin Albert; Anne Gonzalez; Jordan Camarda; Adora Law; Dick Menzies
Journal:  J Thorac Cardiovasc Surg       Date:  2005-09       Impact factor: 5.209

3.  The paradox of on-bypass transfusion thresholds in blood conservation.

Authors:  G Paone; N A Silverman
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

4.  Severe sepsis in cardiac surgical patients.

Authors:  A Michalopoulos; G Stavridis; S Geroulanos
Journal:  Eur J Surg       Date:  1998-03

5.  Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study.

Authors:  D van Dijk; A P Nierich; E W Jansen; H M Nathoe; W J Suyker; J C Diephuis; W J van Boven; C Borst; E Buskens; D E Grobbee; E O Robles De Medina; P P de Jaegere
Journal:  Circulation       Date:  2001-10-09       Impact factor: 29.690

6.  Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements.

Authors:  T K Rosengart; W DeBois; M O'Hara; R Helm; M Gomez; S J Lang; N Altorki; W Ko; G S Hartman; O W Isom; K H Krieger
Journal:  J Thorac Cardiovasc Surg       Date:  1998-02       Impact factor: 5.209

7.  A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass graft surgery.

Authors:  K Karkouti; M M Cohen; S A McCluskey; G D Sher
Journal:  Transfusion       Date:  2001-10       Impact factor: 3.157

Review 8.  Nonhemolytic, noninfectious transfusion reactions.

Authors:  J C Barton
Journal:  Semin Hematol       Date:  1981-04       Impact factor: 3.851

9.  Blood use in patients undergoing coronary artery bypass surgery: impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight.

Authors:  Bharathi H Scott; Frank C Seifert; Peter S A Glass; Roger Grimson
Journal:  Anesth Analg       Date:  2003-10       Impact factor: 5.108

10.  Mini extracorporeal circuit for coronary artery bypass grafting: initial clinical and biochemical results: a comparison with conventional and off-pump coronary artery bypass grafts concerning global oxidative stress and alveolar function.

Authors:  W J van Boven; W B Gerritsen; F G Waanders; F J Haas; L P Aarts
Journal:  Perfusion       Date:  2004-07       Impact factor: 1.972

View more
  3 in total

1.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

3.  Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature.

Authors:  Matthew W Reynolds; John Clark; Sheila Crean; Srinath Samudrala
Journal:  Patient Saf Surg       Date:  2008-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.